SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 201.28-2.1%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RevMikeB who wrote (23316)7/17/1998 6:58:00 PM
From: Machaon  Read Replies (1) of 32384
 
<< They have given me no indication from their past and present actions that dilution will not continue. >>

Funding is a big problem in the biotech sector. Many biotech stocks have to use creative means to get funding.

I don't like stock dilution, but I do like Ligand's deep pipeline, and their scientific breakthrus. Quality cost big bucks.

It has been tough for biotechs, because of reduced government money. Couple that with emaciated stock prices and you have a funding crisis in the sector.

Henry keeps saying that Ligand is underfunded. Ligand needs to get Panretin Gel and ONTAK approved and submit the other three NDA's. I would like to see Ligand able to do a stock offering at about $20 per share so they could enlarge the size of their pipeline, without having to cut any more deals with the large drug companies.

Just my 2 cents after a lousy LGND day at the market.

Good luck to all of the "decent" members of this thread.

Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext